G2TT
来源类型Report
规范类型报告
DOIhttps://doi.org/10.7249/RRA1895-1
来源IDRR-A1895-1
The burden of respiratory syncytial virus: Understanding impacts on the NHS, society and economy
Francesco Fusco; Lucy Hocking; Stephanie Stockwell; Margaretha Bonsu; Sonja Marjanovic; Stephen Morris; Jon Sussex
发表日期2022-05-31
出版年2022
页码26
语种英语
结论
  • Annual healthcare costs and productivity losses in the UK of children under 5 years having RSV total approximately £80 million. This equates to a mean cost of £97 for the NHS per child under 5 with RSV.
  • Just over £14 million of the £80 million is due to productivity losses, £1.5 million due to out-of-pocket expenses incurred by parents/carers and the remaining nearly £65 million due to healthcare costs.
  • The estimated costs are, in part, due to an estimated annual 467,230 GP visits and 33,937 hospitalisations for UK children under 5 with RSV.
  • Estimates suggest that each year in the UK 33 children under 5 die from RSV.
  • While most cases of RSV result in short-term impacts, some children may face long-term respiratory issues later in their life.
  • We estimate that children aged up to 1 years incur 49% of the total annual cost of RSV in children under five, despite only making up 10% of the total population of under 5's.
  • Children born prematurely account for 19% of the total cost burden of RSV in under 5's.
摘要

Respiratory syncytial virus (RSV) is a common respiratory virus that affects large numbers, mainly of children younger than five. The burden of RSV includes not only ill health for the children with the virus, which in severe cases results in hospitalisation, intensive care and even death; but also the emotional and practical burden on the affected families and carers; and the impact that has on productivity in the economy; alongside the costs of providing healthcare.

,

We reviewed recent literature and published data relevant to the UK and used this information to model the costs to the healthcare system and to the wider UK economy in terms of productivity losses of parents/carers. We found healthcare costs and productivity losses in the UK resulting from RSV in children younger than five total approximately £80 million annually. These costs are the consequence, in part, of an estimated 467,000 GP visits per year in the UK for children aged under five with RSV and 34,000 hospitalisations.

,

Our report also presents additional material, identified in the literature review, on the health impacts on affected children and the nature of the burden on parents and families of caring for a young child with RSV. The consequences of RSV are short-term for the majority of cases, but for some there are long term sequelae including poorer respiratory health in later life. RSV is also responsible for the deaths each year in the UK of an estimated 33 children under five.

目录
  • Chapter One

    Study context and aims

  • Chapter Two

    Method

  • Chapter Three

    Key insights into the burden of RSV in the UK

  • Chapter Four

    Discussion and conclusion

主题Child Health ; Economic Burden of Health Care ; Infectious Diseases ; Measuring Health Care Costs ; Respiratory Diseases and Disorders ; United Kingdom
URLhttps://www.rand.org/pubs/research_reports/RRA1895-1.html
来源智库RAND Corporation (United States)
引用统计
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/524808
推荐引用方式
GB/T 7714
Francesco Fusco,Lucy Hocking,Stephanie Stockwell,et al. The burden of respiratory syncytial virus: Understanding impacts on the NHS, society and economy. 2022.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
RAND_RRA1895-1.pdf(832KB)智库出版物 限制开放CC BY-NC-SA浏览
x1653576754251.jpg.p(5KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Francesco Fusco]的文章
[Lucy Hocking]的文章
[Stephanie Stockwell]的文章
百度学术
百度学术中相似的文章
[Francesco Fusco]的文章
[Lucy Hocking]的文章
[Stephanie Stockwell]的文章
必应学术
必应学术中相似的文章
[Francesco Fusco]的文章
[Lucy Hocking]的文章
[Stephanie Stockwell]的文章
相关权益政策
暂无数据
收藏/分享
文件名: RAND_RRA1895-1.pdf
格式: Adobe PDF
文件名: x1653576754251.jpg.pagespeed.ic.GhPCDaJ1LC.jpg
格式: JPEG

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。